The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Specific Pattern of RAS Oncogene Mutations in Follicular Thyroid Tumors
Abstract
The prevalence of H-RAS, K-RAS, and N-RAS gene mutations in thyroid tumors according to malignancy and histology is controversial. Differences in methodology and histological classifications may explain discrepant results. To address this issue, we first performed a pooled analysis of 269 mutations garnered from 39 previous studies. Mutations proved significantly less frequent when detected with direct sequencing than without (12.3% vs. 17%). The rate of mutation involving N-RAS exon 1 (N1) and K-RAS exon 2 (K2) was less than 1%. Mutations of codon 61 of N-RAS (N2) were significantly more frequent in follicular tumors (19%) than in papillary cancers (5%) and significantly more frequent in malignant (25%) than in benign (14%) tumors. H-RAS mutations in codons 12/13 (H1) were found in 2-3% of all types of tumors, but H-RAS mutations in codon 61 (H2) were observed in only 1.4% of tumors, and almost all of them were malignant. K-RAS mutations in exon 1 were found more often in papillary than follicular cancers (2.7% vs. 1.6%) and were sometimes correlated with special epidemiological circumstances. The second part of this study involved analysis of 80 follicular tumors from patients living in Marseille (France) and Kiev (Ukraine). We used direct sequencing after PCR amplification of exons 1 and 2 of the three RAS genes. Common and atypical adenomas were separated using strict cytological criteria. Mutations of H1-RAS were found in 12.5% of common adenomas and one follicular carcinoma (2.9%). Mutations of N2-RAS occurred in 23.3% and 17.6% of atypical adenomas and follicular carcinomas, respectively. These results confirm the predominance of N2-RAS mutations in thyroid follicular tumors and their correlation with malignancy. They support the implication of N2-RAS mutations in the malignant progression of thyroid follicular tumors and the assumption that some atypical adenomas are precursors of follicular carcinomas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
One- and two-step transformations of rat thyroid epithelial cells by retroviral oncogenes.
Fusco, A., Berlingieri, M. T., Di Fiore, P. P., Portella, G., Grieco, M., & Vecchio, G. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.9.3365 · Cited by 270
RetractedHistological Typing of Thyroid Tumours
Hedinger, C. (1988) · Springer eBooks · doi:10.1007/978-3-642-61383-8 · Cited by 630
Rosaí, J., Carcangiu, M. L., & DeLellis, R. A. (1992) · Armed Forces Institute of Pathology eBooks · Cited by 492
High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis.
Lemoine, N. R., Mayall, E. S., Wyllie, F. S., Williams, E. D., Goyns, M. H., Stringer, B. M. J., & Wynford‐Thomas, D. (1989) · PubMed · Cited by 417
Point Mutations of Ras Oncogenes are an Early Event in Thyroid Tumorigenesis
Namba, H., Rubin, S. A., & Fagin, J. A. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-10-1474 · Cited by 356
Follicular-Patterned Lesions of the Thyroid: The Bane of the Pathologist
Baloch, Z. W., & LiVolsi, V. A. (2002) · American Journal of Clinical Pathology · doi:10.1309/8vl9-ecxy-nvmx-2rqf · Cited by 266
Presence of mutations in all three ras genes in human thyroid tumors.
Suarez, H. G., Ja, D. V., Severino, M. E., Caillou, B., Schlumberger, M. J., Tubiana, M., Parmentier, C., & Monier, R. (1990) · PubMed · Cited by 262
Activated ras oncogenes in human thyroid cancers.
Lemoine, N. R., Mayall, E. S., Wyllie, F. S., Farr, C. J., Hughes, D., Padua, R. A., Thurston, V., Williams, E. D., & Wynford‐Thomas, D. (1988) · PubMed · Cited by 233
Prevalence of Ras mutations in thyroid neoplasia
Esapa, C. T., Johnson, S. J., Kendall‐Taylor, P., Lennard, T. W. J., & Harris, P. E. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00704.x · Cited by 220
Ras proteins in the control of the cell cycle and cell differentiation
Crespo, P., & León, J. (2000) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/pl00000645 · Cited by 189
Ras Oncogene Mutations in Benign and Malignant Thyroid Neoplasms
KARGA, H., LEE, J.-K., VICKERY, A. L., THOR, A., GAZ, R. D., & JAMESON, J. L. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-4-832 · Cited by 175
Basolo, F., Pisaturo, F., Pollina, L. E., Fontanini, G., Elisei, R., Molinaro, E., Iacconi, P., Miccoli, P., & Pacini, F. (2000) · Thyroid · doi:10.1089/thy.2000.10.19 · Cited by 155
High rates of ras codon 61 mutation in thyroid tumors in an iodide-deficient area.
Shi, Y., Zou, M., Schmidt, H., Juhász, F., Stensky, V., Robb, D., & Farid, N. R. (1991) · PubMed · Cited by 146
Nikiforov, Y. E., Nikiforova, M. N., Gnepp, D. R., & Fagin, J. A. (1996) · PubMed · Cited by 127
Selective activation of ras oncogenes in follicular and undifferentiated thyroid carcinomas
Manenti, G., Pilotti, S., Re, F. C., Porta, G., & Pierotti, M. A. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)90130-9 · Cited by 126
N-ras mutation: an independent prognostic factor for aggressiveness of papillary thyroid carcinoma.
Hara, H., Fulton, N. C., YASHIRO, T., Ito, K., DeGroot, L. J., & Kaplan, E. L. (1994) · PubMed · Cited by 124
H-Ras Protooncogene Mutations in Human Thyroid Neoplasms*
Namba, H., Gutman, R. A., MATSUO, K., Alvarez, A., & Fagin, J. A. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-1-223 · Cited by 109
Detection of activated ras oncogenes in human thyroid carcinomas.
Suarez, H. G., Ja, D. V., Caillou, B., Schlumberger, M. J., Tubiana, M., Parmentier, C., & Monier, R. (1988) · PubMed · Cited by 106
Prevalence of Activating ras Mutations in Morphologically Characterized Thyroid Nodules
Ezzat, S., Zheng, L., KOLENDA, J., SAFARIAN, A., Freeman, J. L., & Asa, S. L. (1996) · Thyroid · doi:10.1089/thy.1996.6.409 · Cited by 98
Oncogene profile of papillary thyroid carcinoma
Sugg, S. L., Ezzat, S., Zheng, L., Freeman, J. L., Rosen, I. B., & Asa, S. L. (1999) · Surgery · doi:10.1016/s0039-6060(99)70287-4 · Cited by 93
Genetic alterations in human epithelial thyroid tumours
Suarez, H. G. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00443.x · Cited by 81
Yoshimoto, K., Iwahana, H., Fukuda, A., Sano, T., Katsuragi, K., Kinoshita, M., Saito, S., & Itakura, M. (1992) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1992.tb02722.x · Cited by 74
Pattern of ras and gsp oncogene mutations in radiation-associated human thyroid tumors.
Vathaire, C. C.-D., Bounacer, A., Villard, J. A. D., Caillou, B., de Vathaire, F., Monier, R., Schlumberger, M. J., & Suarez, H. G. (1995) · PubMed · Cited by 69
Rochefort, P., Caillou, B., Michiels, F.-M., Ledent, C. A., Talbot, M., Schlumberger, M. J., Lavelle, F., Monier, R., & Feunteun, J. (1996) · PubMed · Cited by 66
Ras Oncogene Mutations in Thyroid Tumors
Capellá, G., Matías‐Guiu, X., Ampudia, X., de Leiva, A., Perucho, M., & Prat, J. (1996) · Diagnostic Molecular Pathology · doi:10.1097/00019606-199603000-00008 · Cited by 66
In vitro reconstruction of tumour initiation in a human epithelium.
Bond, J. A., Wyllie, F. S., Rowson, J., Radulescu, A., & Wynford‐Thomas, D. (1994) · PubMed · Cited by 61
Molecular Genetics of Human Thyroid Neoplasms
Fagin, J. A. (1994) · Annual Review of Medicine · doi:10.1146/annurev.med.45.1.45 · Cited by 57
Gire, V., & Wynford‐Thomas, D. (2000) · Oncogene · doi:10.1038/sj.onc.1203399 · Cited by 49
Ras mutations are rare in solitary cold and toxic thyroid nodules
Krohn, K., Reske, A. P., Ackermann, F., Müller, A., & Paschke, R. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01283.x · Cited by 37
Schark, C., Fulton, N. C., Yashiro, T., Stanislav, G., Jacoby, R. F., Straus, F. H., Dytch, H. E., Bibbo, M., & Kaplan, E. L. (1992) · World Journal of Surgery · doi:10.1007/bf02067375 · Cited by 26
Comparison of Thyroid Peroxidase Expression with Cellular Proliferation in Thyroid Follicular Tumors
Garcia, S., Vassko, V., HENRY, J. F., & Micco, C. D. (1998) · Thyroid · doi:10.1089/thy.1998.8.745 · Cited by 18
Self-citationSpecific PCR Amplification for N-ras Mutations in Neoplastic Thyroid Diseases.
Kaihara, M., Taniyama, M., TADATOMO, J., Tobe, T., Tomita, M., Ito, K., Ban, Y., & Katagiri, T. (1994) · Endocrine Journal · doi:10.1507/endocrj.41.301 · Cited by 6
Cited by
Molecular pathogenesis and mechanisms of thyroid cancer
Xing, M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3431 · Cited by 1,426
BRAF mutation in thyroid cancer
Xing, M. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.0978 · Cited by 1,300
Targeting the MAPK–RAS–RAF signaling pathway in cancer therapy
Santarpia, L., Lippman, S. M., & El-Naggar, A. K. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.645805 · Cited by 1,027
Xing, M. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0007 · Cited by 983
Tohyama, O., Matsui, J., Kodama, K., Hata-Sugi, N., Kimura, T., Okamoto, K., Minoshima, Y., Iwata, M., & Funahashi, Y. (2014) · Journal of Thyroid Research · doi:10.1155/2014/638747 · Cited by 475
Metadata
- Authors
- Vasko, V., Ferrand, M., Di Cristofaro, J., Carayon, P., Henry, J. F., & de Micco, C.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-06-01
- Volume
- 88
- Issue
- 6
- Pages
- 2745-2752
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2011840673
- Cited by
- 310
- References
- 32
- FWCI
- 9.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.